We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    babyee pilot
Previous Study | Return to List | Next Study

Measurement of Energy Metabolism in Infants (BabyEE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02683473
Recruitment Status : Recruiting
First Posted : February 17, 2016
Last Update Posted : February 15, 2018
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Leanne Redman, Pennington Biomedical Research Center

Brief Summary:
The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.

Condition or disease
Infant Development Infant Overnutrition

Detailed Description:

This study intends to establish the feasibility of undertaking comprehensive metabolic phenotyping in infants. The overarching aim is to complete a prospective assessment of energy expenditure in the new infant metabolic chamber approximately one week apart to determine the accuracy and precision of infant protocols related to energy metabolism (sleeping metabolic rate, resting metabolic rate, diet-induced thermogenesis), physical activity, and sucking behavior. This cross-sectional study will answer the following questions:

  1. What is the test re-test reliability of measuring energy expenditure (sleeping metabolic rate, resting metabolic rate, diet-induced thermogenesis) in an infant under the same conditions, 5-7 days apart?
  2. What is the reliability of 24h energy expenditure estimated by the infant metabolic chamber in comparison to a 7-day doubly labeled water study?
  3. How do energy expenditure measurements in infants need to be adjusted to account for variability in infant size and body composition?

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Measurement of Energy Metabolism in Infants: BabyEE Pilot
Study Start Date : February 2016
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018

Infants aged 1-3 months

Primary Outcome Measures :
  1. Energy Expenditure [ Time Frame: Between 1 and 3 months of age ]
    Infant metabolic chamber and doubly labeled water

Secondary Outcome Measures :
  1. Infant sucking behavior [ Time Frame: Between 1 and 3 months of age ]
    Neonur device used on an infant bottle

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   1 Month to 3 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Full-term infants aged 1 to 3 months who are exclusively fed breast milk and/or infant formula will be recruited

Inclusion Criteria:

  • Healthy, full-term infant
  • Aged 1 month (28 days) to 3 months (12 weeks, 6 days)
  • Exclusively fed breast milk and/or infant formula
  • Willing to accept doubly-labeled water
  • If breastfed, willing to feed from a feeding bottle device similar to an infant feeding bottle
  • If breastfed, willing to accept pumped breast milk for some of the study procedures

Exclusion Criteria:

  • Unable to complete 2 clinic visits 5-7 days apart at Pennington Biomedical Research Center
  • Unable or unwilling to eat from an infant feeding bottle
  • Born preterm (< 37 weeks gestation)
  • Congenital abnormality or disability
  • Exposure to gestational diabetes
  • Gastric reflux
  • Acute illness within 7 days of the study (fever, diarrhea)
  • Use of medications to treat a chronic condition (does not include use of vitamin supplements or PRN medication for flatulence)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02683473

Contact: Abby Altazan, M.S. (225) 763-2801 abby.altazan@pbrc.edu

United States, Louisiana
Pennington Biomedical Research Center Recruiting
Baton Rouge, Louisiana, United States, 70808
Contact: Abby Duhé, M.S.    225-763-2801    abby.duhe@pbrc.edu   
Principal Investigator: Leanne M Redman, Ph.D.         
Sub-Investigator: Eric Ravussin, Ph.D.         
Sub-Investigator: Abby Duhé Altazan, M.S.         
Sub-Investigator: Daniel Hsia, M.D.         
Sponsors and Collaborators
Pennington Biomedical Research Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: Leanne M Redman, Ph.D. Pennington Biomedical Research Center

Responsible Party: Leanne Redman, Principal Investigator, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier: NCT02683473     History of Changes
Other Study ID Numbers: PBRC 2015-061
P30DK072476-10 ( U.S. NIH Grant/Contract )
First Posted: February 17, 2016    Key Record Dates
Last Update Posted: February 15, 2018
Last Verified: February 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Infant Nutrition Disorders
Nutrition Disorders